Aromatase inhibitor therapy in recurrent, estrogen-receptor positive uterine serous carcinoma: A case report

Bibliographic Details
Main Authors: Omar Najjar, Aaron Varghese, Maryam Shahi, Russell Vang, Stephanie Gaillard, Thomas Smith, Amanda N. Fader
Format: Article
Language:English
Published: Elsevier 2020-05-01
Series:Gynecologic Oncology Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2352578920300217
id doaj-2d7d1898f7da44249c4df9e62f8b9af0
record_format Article
spelling doaj-2d7d1898f7da44249c4df9e62f8b9af02020-11-25T02:33:18ZengElsevierGynecologic Oncology Reports2352-57892020-05-0132Aromatase inhibitor therapy in recurrent, estrogen-receptor positive uterine serous carcinoma: A case reportOmar Najjar0Aaron Varghese1Maryam Shahi2Russell Vang3Stephanie Gaillard4Thomas Smith5Amanda N. Fader6The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, MD 21205, United StatesThe Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, MD 21205, United StatesDepartment of Pathology, Johns Hopkins School of Medicine, Baltimore, MD 21205, United StatesDepartment of Pathology, Johns Hopkins School of Medicine, Baltimore, MD 21205, United StatesThe Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, MD 21205, United States; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD 21205, United StatesSidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD 21205, United StatesThe Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, MD 21205, United States; Corresponding author at: 600 N. Wolfe St., Phipps Bldg., Rm 281, Baltimore, MD 21287, United States.http://www.sciencedirect.com/science/article/pii/S2352578920300217
collection DOAJ
language English
format Article
sources DOAJ
author Omar Najjar
Aaron Varghese
Maryam Shahi
Russell Vang
Stephanie Gaillard
Thomas Smith
Amanda N. Fader
spellingShingle Omar Najjar
Aaron Varghese
Maryam Shahi
Russell Vang
Stephanie Gaillard
Thomas Smith
Amanda N. Fader
Aromatase inhibitor therapy in recurrent, estrogen-receptor positive uterine serous carcinoma: A case report
Gynecologic Oncology Reports
author_facet Omar Najjar
Aaron Varghese
Maryam Shahi
Russell Vang
Stephanie Gaillard
Thomas Smith
Amanda N. Fader
author_sort Omar Najjar
title Aromatase inhibitor therapy in recurrent, estrogen-receptor positive uterine serous carcinoma: A case report
title_short Aromatase inhibitor therapy in recurrent, estrogen-receptor positive uterine serous carcinoma: A case report
title_full Aromatase inhibitor therapy in recurrent, estrogen-receptor positive uterine serous carcinoma: A case report
title_fullStr Aromatase inhibitor therapy in recurrent, estrogen-receptor positive uterine serous carcinoma: A case report
title_full_unstemmed Aromatase inhibitor therapy in recurrent, estrogen-receptor positive uterine serous carcinoma: A case report
title_sort aromatase inhibitor therapy in recurrent, estrogen-receptor positive uterine serous carcinoma: a case report
publisher Elsevier
series Gynecologic Oncology Reports
issn 2352-5789
publishDate 2020-05-01
url http://www.sciencedirect.com/science/article/pii/S2352578920300217
work_keys_str_mv AT omarnajjar aromataseinhibitortherapyinrecurrentestrogenreceptorpositiveuterineserouscarcinomaacasereport
AT aaronvarghese aromataseinhibitortherapyinrecurrentestrogenreceptorpositiveuterineserouscarcinomaacasereport
AT maryamshahi aromataseinhibitortherapyinrecurrentestrogenreceptorpositiveuterineserouscarcinomaacasereport
AT russellvang aromataseinhibitortherapyinrecurrentestrogenreceptorpositiveuterineserouscarcinomaacasereport
AT stephaniegaillard aromataseinhibitortherapyinrecurrentestrogenreceptorpositiveuterineserouscarcinomaacasereport
AT thomassmith aromataseinhibitortherapyinrecurrentestrogenreceptorpositiveuterineserouscarcinomaacasereport
AT amandanfader aromataseinhibitortherapyinrecurrentestrogenreceptorpositiveuterineserouscarcinomaacasereport
_version_ 1724814912144801792